Bristol-Myers Squibb Company (BMY) Capital expenditures 2016–2025
Bristol-Myers Squibb Company (BMY) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.3BFY2025 · since FY2016: $1.2B → $1.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.3B | +5.0% |
| FY2024 | $1.2B | +3.2% |
| FY2023 | $1.2B | +8.1% |
| FY2022 | $1.1B | +14.9% |
| FY2021 | $973.0M | +29.2% |
| FY2020 | $753.0M | -9.9% |
| FY2019 | $836.0M | -12.1% |
| FY2018 | $951.0M | -9.9% |
| FY2017 | $1.1B | -13.2% |
| FY2016 | $1.2B | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice